Univest
Univest
  • Markets

Global Health Ltd. (MEDANTA) Share Price rises 3.38% as Medanta trades at Rs 1,471.10

  • September 18, 2026
  • Posted by: Harsh Piplani
  • Category: News
No Comments
Global Health Ltd. Share Price
Global Health Ltd. (MEDANTA) share price rose to Rs 1,471.1 today, up 3.38% from the previous close. Market cap was Rs 37,775.14 crore.

Published: 18 September 2026 at 9:49:48 AM IST

Global Health Ltd. Share Price moved higher today, with Medanta closing at Rs 1,471.10 after a 3.38% gain from the previous close of Rs 1,423.05. The company’s market capitalisation stood at Rs 37,775.14 Cr, placing the move in a meaningful valuation and sector context. The day’s range was Rs 1,441.85 to Rs 1,474, while turnover was Rs 0.78 Cr. Based on the supplied data, the price event is confirmed, but no company-specific catalyst is established.

In this Global Health Ltd. Stock News note, Univest looks at what the share price rise shows in the market context, how the current valuation compares with healthcare peers, and what the company’s reported fundamentals suggest. The Global Health Ltd. Share Price Today move is relevant because it arrives alongside a P/E of 68.79, P/B of 9.31, ROE of 15.12%, ROCE of 19.38%, EPS of 20.69, book value of Rs 152.92 and dividend yield of 0.04%. Investors tracking Global Health Ltd. Stock Gaining Today can use this as a factual snapshot rather than a cause-and-effect story.

Table of Contents

Toggle
  • Global Health Ltd. Share Price Today: Price Action Analysis
  • Global Health Ltd. (MEDANTA) Fundamental Analysis
  • Sector and Industry Context
  • Peer Comparison
  • Why Investors Are Watching Global Health Ltd.
  • About Global Health Ltd.
  • Track Global Health Ltd. Share Price on Univest
  • Frequently Asked Questions
    • Why did Global Health Ltd. share price rise today?
    • What is Global Health Ltd. Share Price today?
    • What is Global Health Ltd. market capitalisation?
    • Is Global Health Ltd. expensive compared with healthcare peers?
    • How do Global Health Ltd. fundamentals look?
    • How does Global Health Ltd. compare with healthcare peers?
    • What should investors monitor in Global Health Ltd. Share Price next?

Global Health Ltd. Share Price Today: Price Action Analysis

Metric Value
Current Price Rs 1,471.1
Previous Close Rs 1,423.05
Today's Move Rs 48.05 (+3.38%)
Open Rs 1,448.7
High Rs 1,474
Low Rs 1,441.85
Turnover Rs 0.78 crore
Market Capitalisation Rs 37,775.14 crore
Market Cap Category Large Cap

Global Health Ltd. (MEDANTA) rose to Rs 1,471.1 from the previous close of Rs 1,423.05, a move of Rs 48.05 or 3.38%. The stock opened at Rs 1,448.7, reached a high of Rs 1,474, recorded a low of Rs 1,441.85.

Global Health Ltd. Share Price Today rose by Rs 48.05, or 3.38%, to Rs 1,471.10. The stock opened at Rs 1,448.70, touched an intraday high of Rs 1,474 and a low of Rs 1,441.85, and finished above the previous close of Rs 1,423.05. Turnover for the session was Rs 0.78 Cr. The supplied data confirms a same-day price rise, but it does not establish a company-specific catalyst.

For readers following Global Health Ltd. Share Price Live and Global Health Ltd. Share Price Update queries, the key fact is that the day ended near the session high and above the opening price. That is the full verified picture available from today’s market action. In market commentary, Univest treats this as a price event first and leaves unsupported reasons aside.

Global Health Ltd. (MEDANTA) Fundamental Analysis

Metric Value
Market Capitalisation Rs 37,775.14 crore
P/E Ratio 68.79x
P/B Ratio 9.31x
ROE 15.12%
ROCE 19.38%
EPS Rs 20.69
Book Value Per Share Rs 152.92
Dividend Yield 0.04%

Global Health Ltd. (MEDANTA) fundamental metrics show P/E 68.79x, P/B 9.31x, ROE 15.12%, ROCE 19.38%. These figures provide context only and are not a buy or sell signal.

Global Health Ltd. has a market capitalisation of Rs 37775.14 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 68.79x, P/B at 9.31x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 15.12% and ROCE of 19.38%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 20.69, book value per share of Rs 152.92, dividend yield of 0.04%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 46.59x, median ROE of 13.23%, median ROCE of 16%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric Value
Sector Healthcare
Industry Hospital & Healthcare Services
Benchmark Scope same industry
Company P/E Ratio 68.79x
Benchmark Median P/E 46.59x
Benchmark Average P/E 100.78x
Benchmark P/E Range 7.22x to 1,561.8x
Company P/B Ratio 9.31x
Benchmark Median P/B 3.86x
Company ROE 15.12%
Benchmark Median ROE 13.23%
Company ROCE 19.38%
Benchmark Median ROCE 16%
Company Market Capitalisation Rs 37,775.14 crore
Benchmark Median Market Cap Rs 499.56 crore

Global Health Ltd. (MEDANTA) is classified under sector: Healthcare and industry: Hospital & Healthcare Services.

Global Health Ltd. (MEDANTA) has a P/E ratio of 68.79x, which is above the benchmark median of 46.59x, a difference of +47.65%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Global Health Ltd. (MEDANTA) has a ROE of 15.12%, which is above the benchmark median of 13.23%, a difference of +14.29%. Global Health Ltd. (MEDANTA) has a ROCE of 19.38%, which is above the benchmark median of 16%, a difference of +21.12%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Apollo Hospitals Enterprise Ltd. APOLLOHOSP 1,25,278.85 60.21 12.99 23.54 21.73
Max Healthcare Institute Ltd. MAXHEALTH 1,00,504.02 69.06 9.21 14.53 14.97
MANIPAL HEALTH ENTERPRI L MANIPALHOS 93,977.12 106.33 5.2 12.95 13.93
Fortis Healthcare Ltd. FORTIS 65,568.12 63.92 6.59 11.32 14.07
Aster DM Healthcare Ltd. ASTERDM 64,586.57 207.99 15.67 13.07 16.22

Global Health Ltd. (MEDANTA) has a P/E ratio of 68.79x compared with the displayed peer median of 69.06x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 15.12% compares with a peer median of 13.07% across the companies shown in the table. ROCE stood at 19.38% versus the displayed peer median of 14.97%, providing a capital-efficiency comparison. Global Health Ltd. (MEDANTA) has a market capitalisation of Rs 37,775.14 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching Global Health Ltd.

  • Global Health Ltd. Share Price rose 3.38% today to Rs 1,471.10, after closing above the previous close of Rs 1,423.05.
  • The day’s turnover was Rs 0.78 Cr, and the stock finished near the intraday high of Rs 1,474.
  • P/E is 68.79 and P/B is 9.31, both above the healthcare industry median in the supplied benchmark set.
  • ROE is 15.12% and ROCE is 19.38%, both above the industry medians of 13.23% and 16%.
  • Market capitalisation of Rs 37,775.14 Cr is close to Narayana Hrudayalaya Ltd. in the supplied peer set.

About Global Health Ltd.

Global Health Ltd., known in the market as Medanta, operates in the Healthcare sector and the Hospital & Healthcare Services industry. The company’s listed identity is tied to hospital-led healthcare delivery, and its market data places it among the larger names in the sector. The supplied figures do not include a segment split or revenue mix, so the company profile here stays focused on the verified listing-level facts.

The business is best viewed through the numbers attached to the current Global Health Ltd. Share Price: market cap of Rs 37,775.14 Cr, EPS of Rs 20.69, book value of Rs 152.92 and dividend yield of 0.04%. Those measures help frame the company’s earnings base, net worth per share and payout history. In Univest research language, that makes the stock a healthcare name where valuation and profitability both matter to the discussion.

Track Global Health Ltd. Share Price on Univest

Use Global Health Ltd. (MEDANTA) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Users can track Global Health Ltd. Share Price on Univest for live updates, valuation ratios, market cap, shareholding pattern, 52-week levels and company insights. The platform also brings together Global Health Ltd. Stock News, Global Health Ltd. News Today, Global Health Ltd. Share News and Global Health Ltd. Financial Results in one place for easier monitoring.

For readers who want a cleaner view of Global Health Ltd. Stock Analysis, Univest also helps follow fundamentals, sector comparison, peer valuation and company news without needing to switch between multiple market pages. That makes it useful for checking the same stock story as the market digests it.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions

Why did Global Health Ltd. share price rise today?

Ans. The supplied data confirms a 3.38% price rise to Rs 1,471.10, but it does not establish a company-specific catalyst. The move is therefore best read as a verified market event, not a stated reason.

What is Global Health Ltd. Share Price today?

Ans. Global Health Ltd. Share Price today is Rs 1,471.10. It gained Rs 48.05, or 3.38%, from the previous close of Rs 1,423.05, and closed near the session high of Rs 1,474.

What is Global Health Ltd. market capitalisation?

Ans. Global Health Ltd. market capitalisation stands at Rs 37,775.14 Cr. That places the company well above the industry median in the supplied healthcare benchmark and close to Narayana Hrudayalaya Ltd. in peer comparisons.

Is Global Health Ltd. expensive compared with healthcare peers?

Ans. The stock trades at a P/E of 68.79 and P/B of 9.31, both above the industry median. Compared with peers, it is around Max Healthcare and above Fortis, but below Aster and Manipal on P/E.

How do Global Health Ltd. fundamentals look?

Ans. The company reports ROE of 15.12%, ROCE of 19.38%, EPS of Rs 20.69, book value of Rs 152.92 and dividend yield of 0.04%. These numbers provide context alongside the higher valuation multiples.

How does Global Health Ltd. compare with healthcare peers?

Ans. Global Health Ltd. has a market cap close to Narayana Hrudayalaya and above Fortis, Dr. Lal Pathlabs and KIMS. Its ROE and ROCE are also stronger than several peers in the supplied comparison set.

What should investors monitor in Global Health Ltd. Share Price next?

Ans. Investors can monitor the next price close, valuation ratios, company results and peer comparison. Univest also tracks market cap, shareholding pattern and sector context, which help place the daily move in a broader framework.



Author: Harsh Piplani
I am Harsh Piplani, an Assistant Content Manager with over 5 years of experience in crafting impactful, result-driven content. I hold a B.Com (Hons) degree and have worked across diverse industries, including education, fintech, healthcare, jewellery, and more. I specialise in content strategy, SEO, and optimisation, ensuring that every piece I create is not just well-written but also well-ranked. I believe content should do more than fill space so as to drive traffic, build authority, and support business growth. I enjoy turning complex ideas into clear, engaging narratives, and, as I like to say, I know how to spin words like a web to influence, structured, strategic, and impossible to ignore. For me, great content sits at the intersection of creativity and performance.

Leave a Reply Cancel reply